Home  /  Resource Library  /  First Line Treatment of Hairy Cell Leukemia with Cladribine Followed by Rituximab Consolidation Significantly Improves Leukemia Free Survival

First Line Treatment of Hairy Cell Leukemia with Cladribine Followed by Rituximab Consolidation Significantly Improves Leukemia Free Survival

Results of a study investigating cladribine combined with rituximab for first line treatment of hairy cell leukemia.